Search tips
Search criteria 


Logo of curroncolLink to Publisher's site
Curr Oncol. 2010 November; 17(6): 1.
PMCID: PMC2993432

In this issue of Current Oncology

I am pleased to welcome our readership to what is the largest collection of manuscripts that we have been able to offer to date. This accomplishment is in large part a result of our increasing capacity to publish complete manuscripts online at, with extended abstracts appearing in the hard copy of the journal. The role of the guest editorialist also continues, and I welcome the contributions of Drs. Steven Narod and David Benatar for their opinions on past and current content (respectively: screening by magnetic resonance imaging in breast cancer and the potential dangers of overreliance on the written consent forms in clinical practice), and to my colleague Dr. Martin Chasen for supplying background on the Canada-wide Terry Fox Research Institute Pan-Canadian Dialogue Series, reports of whose meetings the journal is currently publishing.

Occasionally in the past, I have found it difficult, as editor, to envisage the direction in which Current Oncology should go. After all, we are dealing with a disease that has the potential to involve every site in the body and nearly every specialty within medical practice. However, as the journal matures, and with its increasing acceptance within our oncology community, the impact of its broad mandate has become clear, with an ever-improving quality of submissions and a satisfying and eclectic mix for readers.

As we complete our 17th year of publication, I thank all our sponsors, contributors, and readership— and, of course, our talented and hard working editorial board—for ongoing support. To all, I wish the compliments of the season.

Articles from Current Oncology are provided here courtesy of Multimed Inc.